2025³â 09¿ù 14ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Kinaxis Provides Business Update

Robert Courteau Named Executive Chair, Angel Mendez Named Lead Independent Director
´º½ºÀÏÀÚ: 2024-09-28

OTTAWA, ONTARIO -- Kinaxis Inc. (TSX:KXS) a global leader in end-to-end supply chain orchestration, is providing an update on its business.

The company today announces that Robert Courteau has been named Executive Chair of Kinaxis, effective immediately, and will serve in this role until a permanent CEO is in place. Kinaxis previously announced that John Sicard will be retiring at the end of 2024, and the search for his successor is well underway. As Executive Chair, Mr. Courteau will continue to work closely with John Sicard and the senior leadership team to drive the company’s strategy until a new CEO is in place.

Kinaxis also announces that Angel Mendez has been appointed Lead Independent Director of the Board of Directors.

The Board of Directors has taken decisive action in recent months to refine Kinaxis’ strategy and execution, including engaging a leading management consultant firm, who has been working with the company on initiatives that Kinaxis will implement to increase value, improve profitability margins and capture even more of the $16B supply chain management software market.

“Kinaxis has positive momentum in its business, has earned a reputation for its vision and innovation, and is working with focus and urgency to take the company to the next level,” said Robert Courteau, Executive Chair. “My focus will be on supporting the management team in driving the company’s strategy forward. The Board continues to engage with longer-term and newer shareholders to elicit their views on the business. I look forward to continuing to work closely with fellow directors and management to ensure that the company is optimally positioned to create growing and sustainable value for shareholders.”

The Board values shareholder feedback and since announcing its CEO succession, Kinaxis leadership has been speaking with shareholders and considering the best approaches going forward. The Board strongly believes that execution of its strategic plan is the best path to maximize shareholder value. The company continues to develop and evaluate its plan and has engaged Goldman Sachs to provide financial advice in this regard.

Kinaxis has a proven track record of success and a reputation for delivering excellence for customers and shareholders. Kinaxis is a market leader in AI with its end-to-end orchestration platform Maestro and is a ten-time Leader in Gartner’s Supply Chain Planning Solutions Magic Quadrant.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Energy Dome Inks a Strategic Commercial Agreement with Google
Thoma Bravo Acquires Verint to Join Forces with Calabrio to Create an AI-Driven Customer Experience Powerhouse
Techint, Siemens Win FEED Contract for 210MW Electrolyzer in Pacifico Mexinol Project by Transition Industries
Boomi Named a Leader and Secures Top Score in Strategy Category in Latest iPaaS Report by Independent Research Firm
MRM Health Raises ¢æ55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
Kioxia Achieves Successful Prototyping of 5TB Large-Capacity and 64GB/s High-Bandwidth Flash Memory Module
UL Solutions Opens First Commercial and Service Robot Testing Laboratory

 

Helical Fusion Raises JPY 2.3 Billion Series A, Advances Roadmap for W...
Rimini Street, American Digital Team Up to Offer SAP, Oracle, VMware S...
Hamad Bin Khalifa University to Host Conference on AI Ethics
DNP to Open First Overseas R&D Center in the Netherlands
GCT Semiconductor Successfully Completes Sampling of 5G Chipsets and M...
European Commission Approves Tablet Formulation of BeOne Medicines¡¯ B...
Kioxia Sampling UFS Ver. 4.1 Embedded Flash Memory Devices

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..